Home > Technical Information (page
1 /
2 /
3 /
4
) |
In this web site, technical information about trouble shootings, application examples and
list of reference papers are presented. If you have any questions or any comments,
please feel free to contact us by e-mail.
Some e-mails from free e-mail address would be rejected or be automatically classified as SPAM.
If no repry in 5 business days, please contact us again using another e-mail address or FAX.
Our products are for RESEARCH USE ONLY. Not for diagnostic, medical or other use.
We are making efforts to prevent errors or mistakes on preparing web site documents, instruction manuals and products.
But even if some damage would causedby such faults, we will be exempt from responsibility.
|
|
Type |
Product name / code |
Click below |
DNA oxidation |
8-OHdG Check ELISA (Code. KOG-200SE/ KOG-HS10E) |
Tech Info |
Ref. |
Anti 8-OHdG monoclonal antibody (N45.1) (Code: MOG-020P / MOG-100P) |
Tech Info |
Ref. |
Anti Thymidine Glycol (TG) monoclonal antibody (Code: MTG-100P) |
Tech Info |
Ref. |
Lipid oxidation |
Hexanoyl-Lysine (HEL) ELISA kit (Code: KHL-700E) |
Tech Info |
Ref. |
Anti Hexanoyl-Lysine (HEL) monoclonal antibody (Code: MHL-021P / MHL-020P) |
Tech Info |
Ref. |
Anti 4-HNE monoclonal antibody (HNEJ2) (Code: MHN-020P / MHN-100P) |
Tech Info |
Ref. |
Anti Acrolein (ACR) monoclonal antibody (5F6) (Code: MAR-020n / MAR-100n) |
Tech Info |
Ref. |
Anti MDA monoclonal antibody (1F83) (Code: MMD-030n) |
Tech Info |
Ref. |
Anti 4-hydroxy-2-hexenal (4-HHE) monoclonal antibody (Code: MHH-030n) |
Tech Info |
Ref. |
Anti Crotonaldehyde (CRA) monoclonal antibody (Code: MCA-030n) |
Tech Info |
Ref. |
Anti Methylglyoxal (MG) monoclonal antibody (Code: MMG-030n) |
Tech Info |
Ref. |
Anti 7-ketocholesterol (7-KC) monoclonal antibody (Code: MKC-020n) |
Tech Info |
Ref. |
Protein oxidation |
Dityrosine (DT) ELISA (Code: KDT-010E) |
Tech Info |
Ref. |
Anti Dityrosine (DT) monoclonal antibody (Code: MDT-020P) |
Tech Info |
Ref. |
Anti Dibromo-Tyrosine (DiBrY) monoclonal antibody (Code: MBY-020P) |
Tech Info |
Ref. |
Antioxidant assay |
Total Antioxidant Assay(PAO) (Code: KPA-050) |
Tech Info |
Ref. |
Traceelements Assay |
Fe / Iron Assay Kit (ferrozine) (Code: CFE-005) |
Tech Info |
Ref. |
Fe / Iron Assay Kit (Nitroso-PSAP) (Code: CFE-010) |
Tech Info |
Ref. |
UIBC Assay Kit (Bathophenanthroline) (Code: CBC-800) |
Tech Info |
Ref. |
Cu / Copper Assay Kit (3,5-DiBr-PAESA) (Code: CCU-400) |
Tech Info |
Ref. |
Zn / Zinc Assay Kit (5-Br-PAPS) (Code: CZN-001) |
Tech Info |
Ref. |
Ca / Calsium Assay Kit (Chlorophosphonazo III) (Code: CCA-020) |
Tech Info |
Ref. |
Ca / Calsium Assay Kit (o-Cresolphtalein-Complexone) (Code: CCA-030) |
Tech Info |
Ref. |
Mg / Magnesium Assay Kit (Xyridil Blue-I) (Code: CMG-035) |
Tech Info |
Ref. |
|
|
Anti Acrolein (ACR) antibody |
No. |
Title |
Content |
1 |
Immunohistochemistry: |
1) Paraffin sections were deparaffinized and rehydrated.
2) Sections were quenched for several minutes with 3% hydrogen peroxide, rinsed in PBS, pretreated for 30 min
with 3% nonimmune animal serum in PBS.
3) Sections were incubated overnight at 4°C with a antibody at a dilution of 1 µg/mL.
4) Antibody binding was visualized by the avidin-biotin-immuno peroxidase complex method using the Vectastain
ABC kit (Vector, Burlingame, CA) according to the manufacturer's instructions.
5) 3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen.
6) Hematoxylin or Eosin was used as the counter stain.
Technical notes:
1) Sections from which the primary antibodies were omitted served as negative reaction controls.
2) For frozen materials, samples were fixed in 10% formalin, immersed in 30% sucrose in PBS, embedded at
OCT (Sakura, Tokyo, Japan), and stored at -80°C.
3) For paraffin embedded materials, samples were fixed in 10% formalin, dehydrated,
embedded in paraffin, and stored at room temperature.
4) Microwave treatment improves the target staining, whereas it declines non-specific background.
5) Protease K treatment declines the target staining.
Positive control:
Aortic wall in the renal tissue of diabetic nephropathy or aortic wall of atherosclerosis.
|
2 |
Purified acrolein: |
Acrolein is available from Sigma-Aldrich.
Aldrich,
code#110221 (Acrolein) |
3 |
Western blotting: |
Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates
functional impairment of human apolipoprotein E.
Tamamizu-Kato S, et. al. Biochemistry. 46(28), p8392-8400(2007) |
|
|
Ask a question about anti ACR antibody by e-mail.
|
|
List of references: |
1) |
Protein-bound acrolein: Potential markers for oxidativestress.
K.Uchida, M.Kanematsu, K.Sakai, T.Matsuda, N.Hattori,Y.Mizuno, D.Suzuki,T.Miyata, N.Noguchi, E.Niki,T.Osawa
Proc.Natl.Acad.Sci.USA,95,4882-4887(1998) |
2) |
Protein-bound acrolein: A novel markers of oxidativestress in Alzheimer's Disease.
Noel Y. Calingasan, Koji Uchida, and Gary E.Gibson
Journal of Neurochemistry.72(2),751-756(1999) |
3) |
A 1-Hour Enzyme-Linked Immunosorbent Assay for Quantitation of Acrolein- and Hydroxynonenal-
Modified Proteins by Epitope-Bound CaseinMatrix Method.
K.Satoh,S.Yamada,Y.Koike,Y.Igarashi,S.Toyokuni,T.Kumano,T.Takahata,S.Tsuchida and K.Uchida
Analytical Biochemistry.270,323-328(1999) |
4) |
Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral
blood T lymphocytes. Fonseca AM, Porto G, Uchida K, Arosa FA.
Blood. 97(10), p3152-60 (2001) |
5) |
Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that
covalently binds to thiols. Furuhata A, Nakamura M, Osawa T, Uchida K.
J Biol Chem. 277(31), p27919-27926 (2002) |
6) |
Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis.
Kamelija Zarkovic, Koji Uchida, Danijela Kolenc, Ljiljana Hlupic, Neven Zarkovic
Free Radical Research, 40(6), p543 - 552 (2006) |
7) |
Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates
functional impairment of human apolipoprotein E.
Tamamizu-Kato S, Wong JY, Jairam V, Uchida K, Raussens V, Kato H, Ruysschaert JM, Narayanaswami V:
Biochemistry. 46(28), p8392-8400(2007)
Western blotting of ACR-treated ApoE protein. |
|
Ask a question about anti ACR antibody by e-mail.
|
|
|
Anti Malondialdehyde (MDA) antibody |
No. |
Title |
Content |
1 |
Immunohistochemistry: |
1) Paraffin sections were deparaffinized and rehydrated.
2) Sections were quenched for several minutes with 3% hydrogen peroxide, rinsed in PBS,
pretreated for 30 min with 3% nonimmune animal serum in PBS.
3) Sections were incubated overnight at 4°C with a antibody at a dilution of 1 µg/mL.
4) Antibody binding was visualized by the avidin-biotin-immunoperoxidase complex method
using the Vectastain ABC kit (Vector, Burlingame, CA) according to the manufacturer's instructions.
5) 3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen.
6) Hematoxylin or Eosin was used as the counterstain.
Technical Note
1) Sections from which the primary antibodies were omitted served as negative reaction controls.
2) For frozen materials, samples were fixed in 10% formalin, immersed in 30% sucrose in PBS,
embedded at OCT (Sakura, Tokyo, Japan), and stored at -80°C.
3) For paraffinembedded materials, samples were fixed in 10% formalin, dehydrated,
embedded in paraffin, and stored at room temperature.
4) Microwave treatment improves the target staining, whereas it declines non-specific background.
5) Protease K treatment declines the target staining.
|
|
|
Ask a question about anti MDA antibody by e-mail.
|
|
List of references: |
1) |
Immunochemical detection of a lipofuscin-like fluorophore derivered from malondialdehyde and lysine.
S Yamada, S Kumazawa, T Ishii, T Nakayama, K Itakura, N Shibata, M Kobayashi, K Sakai, T Osawa and K Uchida.
J.Lipid Res. 42, p1187-1196 (2001) |
2) |
Investigation on the Origin of Sperm DNA Fragmentation: Role of Apoptosis, Immaturity and Oxidative Stress.
Muratori M, Tamburrino L, Marchiani S, Cambi M, Olivito B, Azzari C, Forti G, Baldi E
Mol Med. 21,p109-122(2015). doi: 10.2119/molmed.2014.00158. |
|
Ask a question about anti MDA antibody by e-mail.
|
|
|
Anti Methyl glyoxal (MG) antibody |
No. |
Title |
Content |
1 |
Immunohistochemistry: |
1) Paraffin sections were deparaffinized and rehydrated.
2) Sections were quenched for several minutes with 3% hydrogen peroxide, rinsed in PBS,
pretreated for 30 min with 3% nonimmune animal serum in PBS.
3) Sections were incubated overnight at 4°C with a antibody at a dilution of 1 µg/mL.
4) Antibody binding was visualized by the avidin-biotin-immunoperoxidase complex method
using the Vectastain ABC kit (Vector, Burlingame, CA) according to the manufacturer's instructions.
5) 3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen.
6) Hematoxylin or Eosin was used as the counterstain.
Technical Note
1) Sections from which the primary antibodies were omitted served as negative reaction controls.
2) For frozen materials, samples were fixed in 10% formalin, immersed in 30% sucrose in PBS,
embedded at OCT (Sakura, Tokyo, Japan), and stored at -80°C.
3) For paraffinembedded materials, samples were fixed in 10% formalin, dehydrated,
embedded in paraffin, and stored at room temperature.
4) Microwave treatment improves the target staining, whereas it declines non-specific background.
5) Protease K treatment declines the target staining.
|
2 |
Western blotting: |
This antibody can be applied to western blottings.
Reference:
Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses.
Padayatti PS, Ng AS, Uchida K, Glomb MA, Nagaraj RH
Invest Ophthalmol Vis Sci. 42(6), p1299-1304. (2001) |
|
|
Ask a question about anti Methyl glyoxal (MG) antibody by e-mail.
|
|
List of references: |
1) |
Protein modification by a Maillard reaction intermediate methylglyoxal. Immunochemical detection
of fluorescent 5-methylimidazolone derivatives in vivo. Uchida K, Khor OT, Oya T, Osawa T, Yasuda Y, Miyata T
FEBS Lett. 410(2-3), p313-318. (1997) |
2) |
Immunological evidence for methylglyoxal-derived modifications in vivo.
Farrukh A Shamsi, Andreea Partal, Candase Sady, Marcus A Glomb and Ramanakoppa H Nagaraj
J. Biol. Chem., 273(12), p6928-6936 (1998) |
3) |
Methylglyoxal Modification of Protein -Chemical and Immunochemical Characterization of
Methylglyoxal-Arginine Adduct. T.Oya, N.Hattori, Y.Mizuno, S.Miyata, S.Maeda, T.Osawa and K.Uchida
J. Biol. Chem., 274, 18492-18502 (1999) |
4) |
Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and
peritoneal fluid reactive carbonyl compounds.
Miyata T, Horie K, Ueda Y, Fujita Y, Izuhara Y, Hirano H, Uchida K, Saito A, van Ypersele de Strihou C, Kurokawa K
Kidney Int. 58(1), p425-435.(2000) |
5) |
Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses.
Padayatti PS, Ng AS, Uchida K, Glomb MA, Nagaraj RH
Invest Ophthalmol Vis Sci. 42(6), p1299-1304. (2001) |
6) |
High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells.
Padayatti PS, Jiang C, Glomb MA, Uchida K, Nagaraj RH
Curr Eye Res. 23(2), p106-115. (2001) |
7) |
Curcumin Inhibits ROS Formation and Apoptosis in Methylglyoxal-Treated Human Hepatoma G2 Cells.
WEN-HSIUNG CHAN, HSIN-JUNG WU and YAN-DER HSUUW Ann. N.Y. Acad. Sci. 1042: 372-378 (2005) |
8) |
Heat-shock protein 27 is a major methylglyoxal-modified protein in endotherial cells.
Casper G Schalkwijk, Jan van Bezu, Roel C van der Schors, Koji Uchida, Coen DA Stehouwer, Victor WM van Hinsbergh.
FEBS Lett. 580, p1565-1570 (2006)
Erratum to: Heat-shock protein 27 is a major methylglyoxal-modified protein in endotherial cells.
FEBS Lett. 580, p2400 (2006) |
9) |
Methyl glyoxal elevation is associated with oxidative stress in rheumatoid arthritis.
S. Mukhopadhyay, S. Sen, B. Majhi, K. P. Das, M. Kar Free Radical Research 41(5) p507-514(2007) |
10) |
Oxidative stresses induced by glycoxidized human or bovine serum albumin on human monocytes.
Philippe Rondeau, Nihar Ranjan Singh, Henri Caillens, Frank Tallet and Emmanuel Bourdon
Free Radical Biology and Medicine 45(6), p799-812 (2008)
|
|
Ask a question about anti Methyl glyoxal (MG) antibody by e-mail.
|
|
|
Anti Crotonaldehyde (CRA) antibody |
No. |
Title |
Content |
1 |
Immunohistochemistry: |
1) Paraffin sections were deparaffinized and rehydrated.
2) Sections were quenched for several minutes with 3% hydrogen peroxide, rinsed in PBS,
pretreated for 30 min with 3% nonimmune animal serum in PBS.
3) Sections were incubated overnight at 4°C with a antibody at a dilution of 1 µg/mL.
4) Antibody binding was visualized by the avidin-biotin-immunoperoxidase complex method
using the Vectastain ABC kit (Vector, Burlingame, CA) according to the manufacturer's instructions.
5) 3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen.
6) Hematoxylin or Eosin was used as the counterstain.
Technical Note
1) Sections from which the primary antibodies were omitted served as negative reaction controls.
2) For frozen materials, samples were fixed in 10% formalin, immersed in 30% sucrose in PBS,
embedded at OCT (Sakura, Tokyo, Japan), and stored at -80°C.
3) For paraffinembedded materials, samples were fixed in 10% formalin, dehydrated,
embedded in paraffin, and stored at room temperature.
4) Microwave treatment improves the target staining, whereas it declines non-specific background.
5) Protease K treatment declines the target staining.
|
|
|
Ask a question about anti Crotonaldehyde (CRA) antibody by e-mail.
|
|
|
Anti 4-hydroxy-2-hexenal (4-HHE) antibody |
No. |
Title |
Content |
1 |
Immunohistochemistry. |
1) Paraffin sections were deparaffinized and rehydrated.
2) Sections were quenched for several minutes with 3% hydrogen peroxide, rinsed in PBS,
pretreated for 30 min with 3% nonimmune animal serum in PBS.
3) Sections were incubated overnight at 4°C with a antibody at a dilution of 1 µg/mL.
4) Antibody binding was visualized by the avidin-biotin-immunoperoxidase complex method
using the Vectastain ABC kit (Vector, Burlingame, CA) according to the manufacturer's instructions.
5) 3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen.
6) Hematoxylin or Eosin was used as the counterstain.
Technical Note
1) Sections from which the primary antibodies were omitted served as negative reaction controls.
2) For frozen materials, samples were fixed in 10% formalin, immersed in 30% sucrose in PBS,
embedded at OCT (Sakura, Tokyo, Japan), and stored at -80°C.
3) For paraffinembedded materials, samples were fixed in 10% formalin, dehydrated,
embedded in paraffin, and stored at room temperature.
4) Microwave treatment improves the target staining, whereas it declines non-specific background.
5) Protease K treatment declines the target staining.
|
|
|
Ask a question about anti 4-hydroxy-2-hexenal (4-HHE) antibody by e-mail.
|
|
List of references: |
1) |
Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids.
Yamada S, Funada T, Shibata N, Kobayashi M, Kawai Y, Tatsuda E, Furuhata A, Uchida K.
J Lipid Res. 45(4), p626-634 (2004) |
2) |
Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic
amyotrophic lateral sclerosis.
Shibata N, Yamada S, Uchida K, Hirano A, Sakoda S, Fujimura H, Sasaki S, Iwata M, Toi S, Kawaguchi M, Yamamoto T, Kobayashi M
Brain Res. 1019(1-2), p170-177 (2004) |
|
Ask a question about anti 4-hydroxy-2-hexenal (4-HHE) antibody by e-mail.
|
|
|
Anti 7-ketocholesterol (7-KC) antibody |
No. |
Title |
Content |
1 |
Immunohistochemistry: |
1) Wash OCT compound with PBS.
2) Frozen sections were quenched for several minutes with 1% EDTA added 3% hydrogen
peroxide, rinsed in PBS, pretreated for 30 min with 3% nonimmune animal serum in PBS.
3) Sections were incubated overnight at 4°C with a antibody at a dilution of 10 µg/mL.
4) Antibody binding was visualized by the avidin-biotin-immunoperoxidase complex method
using the Vectastain ABC kit (Vector, Burlingame, CA) according to the manufacturer's instructions.
5) 3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen.
6) Hematoxylin or Eosin was used as the counterstain.
Technical Note:
1) Frozen materials only.
2) Sections from which the primary antibodies were omitted served as negative reaction controls.
3) For frozen materials, samples were fixed in 10% formalin, immersed in 30% sucrose in PBS,
embedded at OCT (Sakura, Tokyo, Japan), and stored at -80°C. |
2 |
Fix conditions: |
To fix fresh tissue within 5mm thick, 20% formalin for 24 to 48 hours is recommended. |
3 |
EDTA for H2O2 treatment. |
If Milli-Q water is used, EDTA is not needed. But if EDTA affect your staining results,
add 1% EDTA for hydrogen peroxide solution. |
4 |
Blocking of internal avidin. |
Avidin blocking reagent is available from Vector Laboratories. |
5 |
Secondary antibody: |
The dilution factor may be different depending on the kit used in your laboratory.
For example, dilute x5000 to x10000 rabbit anti-mouse IgG or goat anti-mouse IgG, and incuvate
for 2hours at room temperature. Please refer to manufacturer's instructions. |
6 |
The thickness of samples. |
We recoomend to prepare at 3 to 7 µm thick. |
7 |
Esterified 7-ketocholesteol: |
Rectivity to esterified 7-KC has not been tested, because esterified 7-KC is highly
hydrophobic. |
|
|
Ask a question about anti 7-KC antibody by e-mail.
|
|
List of references: |
1) |
Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects.
Free Radical Biology and Medicine, 41(6), p902-910 (2006)
David A. Larsson, Sarah Baird, Jerome Diinga Nyhalah, Xi-Ming Yuan and Wei Li |
2) |
In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers
for oxidative stress. Free Radical Biology and Medicine 43(5), p695-701(2007)
Hanna Larsson, Ylva Bottiger, Luigi Iuliano and Ulf Diczfalusy |
|
Ask a question about anti 7-KC antibody by e-mail.
|
|
[NOTICE]: Our products are for RESEARCH USE ONLY. Not for diagnostic, medical or other use.
We are making efforts to prevent errors or mistakes on preparing web site documents, instruction manuals and products.
But even if some damage would be caused by such faults, we will be exempt from responsibility.
|
Copyright ©
Genox Corporation. All rights reserved.
|